Novavax reported $4.88M in Interest Expense on Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Agenus AGEN:US $ 13.73M 1.47M
Biocryst Pharmaceuticals BCRX:US $ 24.02M 0.18M
Dynavax Technologies DVAX:US $ 1.68M 0M
Geron GERN:US 1.58M 102K
Mannkind MNKD:US $ 9.09M 3.97M
Moderna Inc MRNA:US 5M 1000K
Novartis NVS:US $ 202M 1M
Peregrine Pharmaceuticals PPHM:US 518K 37K
Pfizer PFE:US $ 293M 29M
Sarepta Therapeutics SRPT:US $ 16.03M 0.23M
Tg Therapeutics TGTX:US $ 3.02M 0.35M